148 related articles for article (PubMed ID: 15317599)
21. Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetes.
Reimer T; Hohberg C; Pfützner AH; Jørgensen C; Jensen KH; Pfützner A
Clin Ther; 2008 Dec; 30(12):2252-62. PubMed ID: 19167585
[TBL] [Abstract][Full Text] [Related]
22. Effect of previous treatment with statins on outcome of patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Lev EI; Kornowski R; Vaknin-Assa H; Ben-Dor I; Brosh D; Teplitsky I; Fuchs S; Battler A; Assali A
Am J Cardiol; 2009 Jan; 103(2):165-9. PubMed ID: 19121430
[TBL] [Abstract][Full Text] [Related]
23. Comparison of daily insulin dose and other antidiabetic medications usage for type 2 diabetes patients treated with an analog basal insulin.
McAdam-Marx C; Yu J; Bouchard J; Aagren M; Brixner DI
Curr Med Res Opin; 2010 Jan; 26(1):191-201. PubMed ID: 19919375
[TBL] [Abstract][Full Text] [Related]
24. Oral hypoglycemics: increased postoperative mortality in coronary risk patients.
Jeger RV; Seeberger MD; Keller U; Pfisterer ME; Filipovic M
Cardiology; 2007; 107(4):296-301. PubMed ID: 17264509
[TBL] [Abstract][Full Text] [Related]
25. Association between time of statin initiation after hospital discharge from acute myocardial infarction and risk of recurrence and mortality in patients > or =65 years of age.
Zhou Z; Rahme E; Pilote L
Am J Cardiol; 2006 Jan; 97(2):155-9. PubMed ID: 16442354
[TBL] [Abstract][Full Text] [Related]
26. Apolipoprotein E genotypes are associated with lipid-lowering responses to statin treatment in diabetes: a Go-DARTS study.
Donnelly LA; Palmer CN; Whitley AL; Lang CC; Doney AS; Morris AD; Donnan PT
Pharmacogenet Genomics; 2008 Apr; 18(4):279-87. PubMed ID: 18334912
[TBL] [Abstract][Full Text] [Related]
27. Continuing metformin when starting insulin in patients with Type 2 diabetes: a double-blind randomized placebo-controlled trial.
Douek IF; Allen SE; Ewings P; Gale EA; Bingley PJ;
Diabet Med; 2005 May; 22(5):634-40. PubMed ID: 15842521
[TBL] [Abstract][Full Text] [Related]
28. The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery.
Le Manach Y; Godet G; Coriat P; Martinon C; Bertrand M; Fléron MH; Riou B
Anesth Analg; 2007 Jun; 104(6):1326-33, table of contents. PubMed ID: 17513620
[TBL] [Abstract][Full Text] [Related]
29. The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study.
Atthobari J; Brantsma AH; Gansevoort RT; Visser ST; Asselbergs FW; van Gilst WH; de Jong PE; de Jong-van den Berg LT;
Nephrol Dial Transplant; 2006 Nov; 21(11):3106-14. PubMed ID: 16720593
[TBL] [Abstract][Full Text] [Related]
30. Cataract in type 2 diabetes mellitus in Isfahan, Iran: incidence and risk factors.
Janghorbani M; Amini M
Ophthalmic Epidemiol; 2004 Dec; 11(5):347-58. PubMed ID: 15590582
[TBL] [Abstract][Full Text] [Related]
31. Statin drugs and risk of advanced prostate cancer.
Platz EA; Leitzmann MF; Visvanathan K; Rimm EB; Stampfer MJ; Willett WC; Giovannucci E
J Natl Cancer Inst; 2006 Dec; 98(24):1819-25. PubMed ID: 17179483
[TBL] [Abstract][Full Text] [Related]
32. Statins and newly diagnosed diabetes.
Jick SS; Bradbury BD
Br J Clin Pharmacol; 2004 Sep; 58(3):303-9. PubMed ID: 15327590
[TBL] [Abstract][Full Text] [Related]
33. Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile.
Meas T; Laloi-Michelin M; Virally M; Peynet J; Giraudeaux V; Kévorkian JP; Guillausseau PJ
Eur J Intern Med; 2009 Mar; 20(2):197-200. PubMed ID: 19327612
[TBL] [Abstract][Full Text] [Related]
34. Compliance and persistence with concomitant statin and oral antihyperglycemic therapy.
Zhang Q; Zhao C; Davies MJ; Radican L; Seck T
Am J Manag Care; 2011 Nov; 17(11):746-52. PubMed ID: 22084894
[TBL] [Abstract][Full Text] [Related]
35. Early-onset type 2 diabetes: higher burden of atherogenic apolipoprotein particles during statin treatment.
Song SH; Gray TA
QJM; 2012 Oct; 105(10):973-80. PubMed ID: 22753665
[TBL] [Abstract][Full Text] [Related]
36. The risk of cancer in users of statins.
Graaf MR; Beiderbeck AB; Egberts AC; Richel DJ; Guchelaar HJ
J Clin Oncol; 2004 Jun; 22(12):2388-94. PubMed ID: 15197200
[TBL] [Abstract][Full Text] [Related]
37. Association of statin use and development of renal dysfunction in type 2 diabetes--the Hong Kong Diabetes Registry.
Luk AO; Yang X; Ma RC; Ng VW; Yu LW; Lau WW; Ozaki R; Chow FC; Kong AP; Tong PC; Chan JC; So W
Diabetes Res Clin Pract; 2010 Jun; 88(3):227-33. PubMed ID: 20236720
[TBL] [Abstract][Full Text] [Related]
38. Effects of background statin therapy on glycemic response and cardiovascular events following initiation of insulin therapy in type 2 diabetes: a large UK cohort study.
Anyanwagu U; Mamza J; Donnelly R; Idris I
Cardiovasc Diabetol; 2017 Aug; 16(1):107. PubMed ID: 28830436
[TBL] [Abstract][Full Text] [Related]
39. Oral antidiabetic agents: 2004.
Lebovitz HE
Med Clin North Am; 2004 Jul; 88(4):847-63, ix-x. PubMed ID: 15308382
[TBL] [Abstract][Full Text] [Related]
40. Underutilization of statins in patients with type 2 diabetes in US clinical practice: a retrospective cohort study.
Fu AZ; Zhang Q; Davies MJ; Pentakota SR; Radican L; Seck T
Curr Med Res Opin; 2011 May; 27(5):1035-40. PubMed ID: 21410303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
